Skip to content

Hydrogen-rich water alleviates postoperative cognitive dysfunction in elderly patients undergoing total hip arthroplasty for femoral neck fracture: a randomized controlled trial

Hydrogen-rich water alleviates postoperative cognitive dysfunction in elderly patients undergoing total hip arthroplasty for femoral neck fracture: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102682
Enrollment
Unknown
Registered
2025-05-19
Start date
2020-08-26
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction

Interventions

hydrogen rich group:orally receive hydrogen-rich water (200 mL, with a hydrogen concentration of 1.6 ppm), every 12 hours for a duration of 7 days, commencing on the day prior to the surgical procedur
celecoxib group: orally receive either celecoxib (0.2 g),every 12 hours for a duration of 7 days, commencing on the day prior to the surgical procedure.
control group:normal saline 200ml, every 12 hours for a duration of 7 days, commencing on the day prior to the surgical procedure.

Sponsors

The Second Affiliated Hospital of Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) age over 70 years old;(2) femoral neck fracture; (3) Unilateral hip replacement was performed in all patients. (4) A simple mental state score greater than 17 points (5) American Society of Anesthesiology (ASA) grade I to II; (6) no infectious disease; (7) The patient or family members jointly sign the consent form.

Exclusion criteria

Exclusion criteria: (1) cerebrovascular history; (2) Communication barriers; (3) Severe organic lesions of liver and kidney function (4) local ulceration of infection with previous history of infection. Diagnostic criteria for POCD: MMSE score less than 17 points, or >=3 points decrease from baseline value. MMSE score: The highest score is 30, with scores >=25 indicating normal cognitive function, 19-24 mild abnormalities, 10-18 moderate abnormalities, and <9 severe cognitive impairment.

Design outcomes

Primary

MeasureTime frame
the occurrence of POCD;

Secondary

MeasureTime frame
Postoperative pain assessment;interleukin-6 (IL-6);C-reactive protein (CRP) ;

Countries

China

Contacts

Public ContactChen Yinzhong

The Second Affiliated Hospital of Shandong First Medical University

cyz5481729@163.com+86 151 6381 9525

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026